Brought to you by 
Royal Philips pays $2.1bn for Spectranetics
04 Sep 2020
Executive Summary
In an effort to strengthen its image-guided therapy business, Royal Philips Electronics NV is paying $38.50 per share (a 28% premium) to acquire fellow public device maker Spectranetics Corp. The deal is valued at $2.1bn including cash and the assumption of debt obligations.
Deal Industry
- Medical Devices
-
Medical Devices
- Laser
-
Surgical Equipment & Devices
- Minimally or Less Invasive
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Royal Philips pays $2.1bn for Spectranetics
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice